Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes

Abstract

The MRI Barkhof—Tintoré criteria have proved to be highly specific for predicting conversion to clinically definite multiple sclerosis in patients with clinically isolated syndromes (CIS), but lacked an optimal sensitivity. In order to improve the accuracy of early multiple sclerosis diagnosis, new imaging criteria have been proposed by Swanton et al. We aimed to evaluate the accuracy of both MRI criteria for dissemination in space to predict conversion from CIS to clinically definite multiple sclerosis. We studied 79 CIS patients with baseline MRI performed within the first 3 months after onset. The sensitivity and specificity of both MRI criteria to predict conversion to clinically definite multiple sclerosis were analysed. The time to develop clinically definite multiple sclerosis from CIS onset, according to each imaging criteria, was studied by Kaplan—Meier survival curves. The overall conversion rate was 75.7% with a median follow-up of 57 months. Barkhof— Tintoré’s criteria showed a sensitivity of 71.9% and a specificity of 77.2%. Swanton’s criteria had a sensitivity of 91.2% and a specificity of 68.1%. Both MRI criteria identified CIS patients with higher risk and faster conversion to clinically definite multiple sclerosis. Swanton’s criteria are simpler and more sensitive than Barkhof—Tintoré‘s criteria, with a slight decrease in specificity. These results reinforce their use in multiple sclerosis diagnosis.

Keywords

clinically isolated syndromes multiple sclerosis MRI diagnostic criteria

Get full access to this article

View all access options for this article.

References

Sadovnick AD , Ebers GC Epidemiology of multiple sclerosis: a critical overview. Can J Neurol Sci 1993; 20: 17-29.

Noseworthy JH , Lucchinetti C. , Rodríguez M. , Weinshenker BG Multiple sclerosis . N Engl J Med 2000; 343: 938-952.

Jacobs LD , Beck RW , Simon JH , et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000; 343: 898-904.

Comi G. , Filippi M. , Barkhof F. , et al. Effect of early interferon treatment on conversion to definite multiple sclerosis. Lancet 2001; 357: 1576-1582.

Kappos L. , Polman CH , Freedman MS , et al. Treatment with interferon beta-1b delays conversion to clinically definite MS in patients with clinically isolated syndromes. Neurology 2006; 67: 1242-1249.

McDonald WI , Compston A. , Edan G. , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127.

Barkhof F. , Filippi M. , Miller DH , et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.

Tintoré M. , Rovira A. , Martínez MJ , et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol 2000; 21: 702-706.

Polman CH , Reingold SC , Edan G. , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘‘McDonald criteria’’. Ann Neurol 2005; 58: 840-846.

10.

Swanton JK , Fernando K. , Dalton CM , et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006; 77: 830-833.

11.

Swanton JK , Rovira A. , Tintoré M. , et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007; 6: 677-686.

12.

Poser CM , Paty DW , Scheinberg L. , et al. New diagnostic criteria for multiple sclerosis: guidelines for research proposals. Ann Neurol 1983; 13: 227-231.

13.

Kurtzke JF Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452.

14.

Tintoré M. , Rovira A. , Brieva L. , et al. Isolated demyelinating syndromes: comparison of CFS oligoclonal bands and different MR imaging criteria to predict conversion to CDMS. Mult Scler 2001; 7: 359-363.

15.

Dalton CM , Brex PA , Miszkiel KA , et al. Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 2002; 52: 47-53.

16.

CHAMPS study group. ( 2002). MRI predictors of early conversion to clinically definite MS in CHAMPS placebo group. Neurology 2002 ; 59: 998-1005.

17.

Tintoré M. , Rovira A. , Río J. , et al. New diagnostic criteria for multiple sclerosis. Application in first demyelinating episode . Neurology 2003; 60: 27-30.

18.

Korteweg T. , Tintoré M. , Uitdehaag B. , et al. MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol 2006; 5: 221-227.

19.

Masjuan J. , Álvarez-Cermeño JC , García-Barragán N. , et al. Clinically isolated syndromes. A new oligoclonal band test accurately predicts conversion to MS . Neurology 2006; 66: 576-578.

20.

Villar ML , García-Barragán N. , Sádaba MC , et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci 2008; 1: 34-37.

21.

Lo CP , Kao HW , Chen SY , et al. Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria. J Neurol Neurosurg Psychiatry 2009; 80: 1107-1109.